Kingdon Capital Management L.L.C. Makes New $11.06 Million Investment in Humana Inc. $HUM

Key Points

• Kingdon Capital Management L.L.C. has invested $11.06 million in Humana Inc., acquiring 41,792 shares, which now represents about 1.2% of its total holdings.
• A number of institutional investors have increased their stakes in Humana, with Cary Street Partners Investment Advisory boosting their stake by 63.9% in the first quarter.
• Humana recently declared a quarterly dividend of $0.885 per share, resulting in an annualized dividend yield of 1.2%, set to be paid on October 31.

Kingdon Capital Management L.L.C. purchased a new stake in shares of Humana Inc. (NYSE:HUM - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 41,792 shares of the insurance provider's stock, valued at approximately $11,058,000. Humana makes up about 1.2% of Kingdon Capital Management L.L.C.'s investment portfolio, making the stock its 18th biggest position.

Other hedge funds and other institutional investors have also modified their holdings of the company. Cary Street Partners Investment Advisory LLC raised its holdings in shares of Humana by 63.9% during the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock valued at $31,000 after purchasing an additional 46 shares in the last quarter. Riverview Trust Co bought a new position in shares of Humana during the 1st quarter valued at $34,000. Garde Capital Inc. bought a new position in shares of Humana during the 1st quarter valued at $36,000. Zions Bancorporation National Association UT bought a new position in shares of Humana during the 1st quarter valued at $37,000. Finally, Whipplewood Advisors LLC raised its holdings in shares of Humana by 639.1% during the 1st quarter. Whipplewood Advisors LLC now owns 170 shares of the insurance provider's stock valued at $45,000 after purchasing an additional 147 shares in the last quarter. Institutional investors own 92.38% of the company's stock.

Analyst Ratings Changes

Several research analysts recently commented on HUM shares. Piper Sandler dropped their target price on shares of Humana from $288.00 to $272.00 and set a "neutral" rating on the stock in a report on Thursday, July 31st. Truist Financial dropped their target price on shares of Humana from $280.00 to $260.00 and set a "hold" rating on the stock in a report on Wednesday, July 16th. Robert W. Baird dropped their target price on shares of Humana from $300.00 to $297.00 and set a "neutral" rating on the stock in a report on Friday, July 25th. Wells Fargo & Company dropped their target price on shares of Humana from $348.00 to $344.00 and set an "overweight" rating on the stock in a report on Thursday, August 14th. Finally, Barclays set a $275.00 target price on shares of Humana and gave the stock an "equal weight" rating in a report on Thursday, July 31st. Seven investment analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the company's stock. Based on data from MarketBeat, Humana currently has an average rating of "Hold" and a consensus price target of $285.76.

Humana Price Performance

NYSE:HUM traded up $2.16 on Wednesday, reaching $312.22. The stock had a trading volume of 1,739,373 shares, compared to its average volume of 1,706,351. The company has a market capitalization of $37.55 billion, a P/E ratio of 23.96, a price-to-earnings-growth ratio of 1.79 and a beta of 0.44. Humana Inc. has a 1-year low of $206.87 and a 1-year high of $382.72. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 0.69. The stock has a fifty day moving average price of $257.24 and a 200-day moving average price of $255.32.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The firm had revenue of $32.39 billion during the quarter, compared to analyst estimates of $31.85 billion. During the same quarter last year, the firm earned $6.96 earnings per share. Humana's quarterly revenue was up 9.6% on a year-over-year basis. Humana has set its FY 2025 guidance at 17.000- EPS. Research analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a $0.885 dividend. The ex-dividend date is Friday, September 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.1%. Humana's dividend payout ratio (DPR) is 27.17%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.